BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21600538)

  • 1. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
    Jacobson D; Tagoe C; Schwartzbard A; Shah A; Koziol J; Buxbaum J
    Am J Cardiol; 2011 Aug; 108(3):440-4. PubMed ID: 21600538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Buxbaum J; Alexander A; Koziol J; Tagoe C; Fox E; Kitzman D
    Am Heart J; 2010 May; 159(5):864-70. PubMed ID: 20435197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
    Connors LH; Prokaeva T; Lim A; Théberge R; Falk RH; Doros G; Berg A; Costello CE; O'Hara C; Seldin DC; Skinner M
    Am Heart J; 2009 Oct; 158(4):607-14. PubMed ID: 19781421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amyloidogenic V122I transthyretin variant in elderly black Americans.
    Quarta CC; Buxbaum JN; Shah AM; Falk RH; Claggett B; Kitzman DW; Mosley TH; Butler KR; Boerwinkle E; Solomon SD
    N Engl J Med; 2015 Jan; 372(1):21-9. PubMed ID: 25551524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
    Buxbaum JN; Ruberg FL
    Genet Med; 2017 Jul; 19(7):733-742. PubMed ID: 28102864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans.
    Jacobson DR; Alexander AA; Tagoe C; Buxbaum JN
    Amyloid; 2015; 22(3):171-4. PubMed ID: 26123279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans.
    Selvaraj S; Claggett B; Minamisawa M; Windham BG; Chen LY; Inciardi RM; Buxbaum JN; Mosley TH; Shah AM; Solomon SD
    J Am Coll Cardiol; 2021 Jul; 78(1):89-91. PubMed ID: 33957237
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population.
    Kozlitina J; Garg S; Drazner MH; Matulevicius SA; Ayers C; Overton J; Reid J; Baras A; Rao K; Pandey A; Berry J; de Lemos JA; Grodin JL
    J Card Fail; 2022 Mar; 28(3):403-414. PubMed ID: 34634447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.
    Buxbaum J; Koziol J; Connors LH
    Amyloid; 2008 Dec; 15(4):255-61. PubMed ID: 19065297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
    Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
    Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease and Mortality in Black Women Carrying the Amyloidogenic V122I Transthyretin Gene Variant.
    Haring B; Hunt RP; Shadyab AH; Eaton C; Kaplan R; Martin LW; Panjrath G; Kuller LH; Assimes T; Kooperberg C; Wassertheil-Smoller S
    JACC Heart Fail; 2023 Sep; 11(9):1189-1199. PubMed ID: 36930136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
    Dungu JN; Papadopoulou SA; Wykes K; Mahmood I; Marshall J; Valencia O; Fontana M; Whelan CJ; Gillmore JD; Hawkins PN; Anderson LJ
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27618855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
    Parker MM; Damrauer SM; Tcheandjieu C; Erbe D; Aldinc E; Hawkins PN; Gillmore JD; Hull LE; Lynch JA; Joseph J; Ticau S; Flynn-Carroll AO; Deaton AM; Ward LD; Assimes TL; Tsao PS; Chang KM; Rader DJ; Fitzgerald K; Vaishnaw AK; Hinkle G; Nioi P
    Sci Rep; 2021 Jun; 11(1):11645. PubMed ID: 34079032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
    Agbor-Etang BB; Okafor HE; Farber-Eger EH; Wells QS
    Am J Med; 2021 Feb; 134(2):e98-e100. PubMed ID: 32866461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
    Dungu J; Sattianayagam PT; Whelan CJ; Gibbs SD; Pinney JH; Banypersad SM; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Hawkins PN; Anderson LJ
    Am Heart J; 2012 Jul; 164(1):72-9. PubMed ID: 22795285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans.
    Minamisawa M; Inciardi RM; Claggett B; Cuddy SAM; Quarta CC; Shah AM; Dorbala S; Falk RH; Matsushita K; Kitzman DW; Chen LY; Solomon SD
    Eur J Heart Fail; 2021 Aug; 23(8):1290-1295. PubMed ID: 33928732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
    Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
    Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.
    Hamour IM; Lachmann HJ; Goodman HJ; Petrou M; Burke MM; Hawkins PN; Banner NR
    Am J Transplant; 2008 May; 8(5):1056-9. PubMed ID: 18318779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.